Login / Signup

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.

Walter Robert John TaylorSaorin KimSim KhengSinoun MuthPety TorEva ChristophelMavuto MukakaAlexandra KerleguerLucio LuzzattoJ Kevin BairdDidier Ménard
Published in: PLoS neglected tropical diseases (2021)
The trial was registered (ACTRN12613000003774) with the Australia New Zealand Clinical trials (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=363399&isReview=true).
Keyphrases
  • clinical trial
  • phase iii
  • phase ii
  • study protocol
  • open label
  • plasmodium falciparum
  • stem cells
  • cell therapy